FDA Inspection 603167 — Strides Pharma, Inc.

Strides Pharma, Inc. — FEI 2434223

The FDA completed an inspection of Strides Pharma, Inc. on August 7, 2009 in Chestnut Ridge, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 7, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chestnut Ridge, NY (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
202721 CFR 211.192Investigations of discrepancies, failures
359221 CFR 211.110(c)In-process materials characteristics testing